Originally published by Er J. Wouters, Panos G. Kavanos, Martin McKee in The Milbank Quarterly, 95: 554–601 under a Creative Commons License. Abstract Policy Points: Our study indicates that there are opportunities…
The post Comparing Generic Dru…
This article was originally published by Ekaterina Galkina Cleary, Jennifer M. Beierlein, Navleen Surjit Khanuja, Laura M. McNamee and Fred D. Ledley in PNAS under a Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC…
The po…
Contribution of NIH funding to new drug approvals 2010–2016 Read Post »
This article was originally published by Christopher Southan, Peter Varkonyi, Kiran Boppana, Sarma A.R.P. Jagarlapudi, and Sorel Muresan at PLoS ONE 8(10): e77142. Abstract The statistics of drug development output and…
The post Tracking 20 Years…
Tracking 20 Years of Compound-to-Target Output from Literature and Patents Read Post »
This article was originally published on November 30th 2017 by Hamish McDougall and Alaric DeArment of BioPharm Insight, part of GlobalData. Polymorph differences support noninfringement argument Trace solvate amount could destabalise…
The post C…
Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately by the biopharmaceutical sector,…
The post Making Medicines Affordable…
Making Medicines Affordable: A National Imperative Read Post »
This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…
We must achieve a balance between the current and future needs of patients and the timely introduction of existing and new pharmaceutical drugs Dr. Ashish Bharadwaj is a faculty member at…
The post Balancing Patents and Drug Prices appeared first…
This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which presents ways to innovate, be flexible, and do more with…
The post Leveraging affordabl…
Leveraging affordable innovation to tackle India’s healthcare challenge Read Post »
This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research 2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 © The Author(s). 2017 Abstract Background Policymakers and researchers frequently com…
In the complex world of intellectual property and pharmaceutical development, understanding the intricacies of patent term extension (PTE) is crucial […]
